Cannara Biotech's total assets for Q2 2025 were C$161.41M, an increase of 0.25% from the previous quarter. TSE:LOVE total liabilities were C$67.22M for the fiscal quarter, a -4.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.